| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |